New in this edition:* Third-generation antipsychotics with major additions and changes * Pharmacogenomics fully revised * ECT thoroughly revised and updated* BLT / rTMS with extended references* Extrapyramidal side effects chart extended* Antidepressants vilazodone and vortioxetine with extended coverage * New chart of agents under investigation for treatment of substance use disorders* Approved and off-label indications updated* New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depres-sion, dementia, schizophrenia, and anxiety disorders* New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant (Belsomra)* New formulations and trade names include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quil-livant XRThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.* Independent, unbiased* Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options* Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing impli-cations, and much more - all you need to know for each class of drug* Potential interactions and side effects summarized in comparison charts* With instantly recognizable icons and in full color throughout, allow-ing you to find at a glance all the information you seek * Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs
"Sinopsis" puede pertenecer a otra edición de este libro.
Ric M. Procyshyn; BSc (Pharm), MSc, PharmD, PhD; Department ofPsychiatry, University of British Columbia, Vancouver, BC, Canada;British Columbia Mental Health & Addictions Research Institute,Vancouver, BC, Canada.Kalyna Z. Bezchlibnyk-Butler; BScPhm, FCSHP; Toronto, ON, Canada.J. Joel Jeffries; MB, FRCPC, DFCPA; Centre for Addiction and MentalHealth and Department of Psychiatry, University of Toronto,Toronto, ON, Canada.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: World of Books (was SecondSale), Montgomery, IL, Estados Unidos de America
Paperback. Condición: Good. The classic reference to psychotropic medications, with substantial revisions and updates: packed with new and expanded comparison charts, the latest drugs, completely revised sections on ECT and pharmacogenomics, and much more! Nº de ref. del artículo: 00109042246
Cantidad disponible: 1 disponibles
Librería: World of Books Inc, Montgomery, IL, Estados Unidos de America
Paperback. Condición: Good. The classic reference to psychotropic medications, with substantial revisions and updates: packed with new and expanded comparison charts, the latest drugs, completely revised sections on ECT and pharmacogenomics, and much more! Nº de ref. del artículo: CIN0889374961G
Cantidad disponible: 1 disponibles
Librería: Zoom Books Company, Lynden, WA, Estados Unidos de America
Condición: very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service. Nº de ref. del artículo: ZBV.0889374961.VG
Cantidad disponible: 1 disponibles
Librería: Hawking Books, Edgewood, TX, Estados Unidos de America
Condición: Very Good. Very Good Condition. Five star seller - Buy with confidence! Nº de ref. del artículo: X0889374961X2
Cantidad disponible: 1 disponibles
Librería: HPB-Red, Dallas, TX, Estados Unidos de America
Spiral-bound. Condición: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Nº de ref. del artículo: S_383435841
Cantidad disponible: 1 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Spiralbindung. Condición: Sehr gut. Gebraucht - Sehr gut SG - leichte Beschädigungen oder Verschmutzungen, ungelesenes Mängelexemplar, gestempelt - The Clinical Handbook of Psychotropic Drugs has become a standardreference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. - Independent, unbiased - Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions.) for a quick overview of treatment options - Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug - Potential interactions and side effects summarized in comparison charts - With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek - Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-touse, comprehensive summary of all the most relevant information about psychotropic drugs. New in this edition: - Third-generation antipsychotics with major additions and changes - Pharmacogenomics fully revised - ECT thoroughly revised and updated - BLT / rTMS with extended references - Extrapyramidal side effects chart extended - Antidepressants vilazodone and vortioxetine with extended coverage - New chart of agents under investigation for treatment of substance use disorders - Approved and off-label indications updated - New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disorders - New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant (Belsomra) - New formulations and tradenames include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XR. Nº de ref. del artículo: INF1000522081
Cantidad disponible: 3 disponibles